Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Brock PR"'
Autor:
Clemens, Eva, Van den Heuvel - Eibrink, Marry, Mulder, RL, Kremer, LCM (Leontien), Hudson, MM, Skinner, R, Constine, LS, Bass, JK, Kuehni, CE, Langer, T, van Dalen, EC, Bardi, E, Bonne, NX, Brock, PR, Brooks, B, Carleton, B, Caron, E, Chang, KW, Johnston, K, Knight, K, Nathan, PC, Orgel, E, Prasad, PK, Rottenberg, J, Scheinemann, K, de Vries, A.C.H., Walwyn, T, Weiss, A, Zehnhoff-Dinnesen, AA, Cohn, RJ, Landier, W, Kadan-Lottick, N, Levitt, G, Hoetink, A, Mussman, J
Publikováno v:
Lancet Oncology
Lancet Oncology, 2019, 20 (1), pp.e29-e41. ⟨10.1016/S1470-2045(18)30858-1⟩
Lancet Oncol
Lancet Oncology, 20(1), E29-E41. Lancet Publishing Group
The Lancet Oncology
The Lancet Oncology, 2019, 20 (1), pp.e29-e41. ⟨10.1016/S1470-2045(18)30858-1⟩
Lancet Oncology, 2019, 20 (1), pp.e29-e41. ⟨10.1016/S1470-2045(18)30858-1⟩
Lancet Oncol
Lancet Oncology, 20(1), E29-E41. Lancet Publishing Group
The Lancet Oncology
The Lancet Oncology, 2019, 20 (1), pp.e29-e41. ⟨10.1016/S1470-2045(18)30858-1⟩
International audience; Childhood, adolescent, and young adult (CAYA) cancer survivors treated with platinum-based drugs, head or brain radiotherapy, or both have an increased risk of ototoxicity (hearing loss, tinnitus, or both). To ensure optimal c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52c9691c172f35b13ef8adca102c2338
https://www.hal.inserm.fr/inserm-02941725
https://www.hal.inserm.fr/inserm-02941725
Autor:
Brock PR, Maibach R, Childs M, Rajput K, Roebuk D, Sullivan MJ, Laithier V, Ronghe M, Dall'Igna P, Hiyama E, Brichard B
Publikováno v:
N Engl J Med, Vol. 25, no.378, p. 2376-2385 (2018)
Sodium thiosulfate for protection from cisplatin-induced hearing loss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1493::de0442e557cca78f69ddf2ed6a9d88dc
https://hdl.handle.net/2078.1/213039
https://hdl.handle.net/2078.1/213039
Autor:
Burchill, SA, Beiske, K, Shimada, H, Ambros, PF, Seeger, R, Tytgat, GAM, Brock, PR, Haber, M, Park, JR, Berthold, F
BACKGROUND: The current study was conducted to expedite international standardized reporting of bone marrow disease in children with neuroblastoma and to improve equivalence of care. METHODS: A multidisciplinary International Neuroblastoma Response C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::4da1f7aba72b76c40bc70122bf0affa5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Meijer AJM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Diepstraten FA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Ansari M; Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Division of Pediatric Oncology and Hematology, Department of Women, Child and Adolescent, University Geneva Hospitals, Geneva, Switzerland., Bouffet E; Division of Pediatric Neuro-Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Bleyer A; Department of Radiation Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, Canada., Fresneau B; Department of Children and Adolescents Oncology, Gustave Roussy, University Paris Saclay and Radiation Epidemiology Team, CESO, Inserm U1018, Villejuif, France., Geller JI; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH., Huitema ADR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Kogner P; Department of Pediatric Oncology and Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, Sweden., Maibach R; ETOP IBCSG Partners Foundation, Bern, Switzerland., O'Neill AF; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Papadakis V; Department of Pediatric Hematology-Oncology (TAO), Agia Sofia Children's Hospital, Athens, Greece., Rajput KM; Department of Pediatric Audiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom., Veal GJ; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Sullivan M; Children's Cancer Centre and Department of Pediatric Oncology, Royal Children's Hospital, Melbourne, Victoria, Australia., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Wilhelmina Childrens' Hospital, Division of Child Health, Utrecht, the Netherlands., Brock PR; Department of Pediatric Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 20; Vol. 42 (18), pp. 2219-2232. Date of Electronic Publication: 2024 Apr 22.
Autor:
Brock PR; Oncology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom.
Publikováno v:
Cancer [Cancer] 2022 Jan 01; Vol. 128 (1), pp. 43-46. Date of Electronic Publication: 2021 Sep 07.
Autor:
Meijer AJM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Heuvel-Eibrink MM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands., Brooks B; Department of Audiology and Speech Pathology, BC Children's Hospital, Vancouver, British Columbia, Canada.; School of Audiology and Speech Science, University of British Columbia, Vancouver, British Columbia, Canada., Am Zehnhoff-Dinnesen AG; Department of Phoniatrics and Pedaudiology, University Hospital Muenster, Westphalian Wilhelm University, Muenster, Germany., Knight KR; Department of Pediatric Audiology, Oregon Health and Science University, Portland., Freyer DR; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California.; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles.; Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles.; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles., Chang KW; Department of Otolaryngology, Stanford University School of Medicine, Palo Alto, California., Hero B; Department of Pediatric Hematology-Oncology, Children's Hospital, University of Cologne, Cologne, Germany., Papadakis V; Department of Pediatric Hematology-Oncology, Agia Sofia Children's Hospital, Athens, Greece., Frazier AL; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts., Blattmann C; Department of Pediatric Oncology/Hematology/Immunology, Stuttgart Cancer Center, Olgahospital Stuttgart, Stuttgart, Germany., Windsor R; Department of Oncology, University College London Hospitals National Health Service Trust, London, United Kingdom., Morland B; Department of Pediatric Oncology, Birmingham Children's Hospital, Birmingham, United Kingdom., Bouffet E; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany., Tytgat GAM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Geller JI; Division of Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio., Hunter LL; Communication Sciences Research Center, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio., Sung L; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, Toronto, Canada., Calaminus G; Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany., Carleton BC; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada., Helleman HW; Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht-Wilhelmina Children's Hospital, Utrecht, the Netherlands., Foster JH; Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Houston, Texas., Kruger M; Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa., Cohn RJ; Kids Cancer Centre, Sydney Children's Hospital, High Street, Randwick, Australia.; School of Women's and Children's Health, University of New South Wales Medicine, Sydney, Australia., Landier W; Department of Pediatrics, Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham., van Grotel M; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Brock PR; Department of Pediatric Oncology, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom., Hoetink AE; Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht-Wilhelmina Children's Hospital, Utrecht, the Netherlands., Rajput KM; Department of Audiovestibular Medicine and Cochlear Implant, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom.
Publikováno v:
JAMA oncology [JAMA Oncol] 2021 Oct 01; Vol. 7 (10), pp. 1550-1558.